Bio-Thera’s Bevacizumab US Action Date Passes Without Approval

Chinese Developer And Partner Sandoz Remain Quiet On Fate Of Avastin Biosimilar

 
• By David Wallace
  
27 November 2021 calendar date marked
The 27 November action date has come and gone • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products